ClinicalTrials.gg
CompletedNCT06392919Updated Sep 29, 2026

The Impact of Repetitive Transcranial Magnetic Stimulation on the Prognosis of Elderly Surgical Patients

An interventional study of Repetitive Transcranial Magnetic Stimulation in Postoperative Delirium, Postoperative Cognitive Dysfunction and Chronic Post-surgical Pain, sponsored by Affiliated Hospital of Nantong University. Completed at 1 site in China. Open to participants aged 60 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-09-29.

Sponsored by Affiliated Hospital of Nantong University · Not applicable, Interventional, and Prevention

How we know

Updated Sep 29, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
352
Allocation
Randomized
Ages
60 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 185 studies in Emergence Delirium with a site in China — 64 open to participants now, 65 under way, 1 of them phase 3. Emergence Delirium · China.

Enrollment
38th of 111
352 · median 225
Started
2024
with 29 others
No phase
70 of 185
29 open now
Registered
105th of 185
by date
Lead sponsor
4 of 185
Affiliated Hospital of Nantong University

Among the 185 studies in Emergence Delirium with a site in China, this one is the 38th largest by enrollment of the 111 interventional ones that give a count, is one of 30 that started in 2024, is one of 70 with no phase, and was the 105th registered.

Emergence Delirium

753 studies on the registry are indexed under Emergence Delirium; 261 are open to participants now.

Browse Emergence Delirium studies →

Open to participants now

64 of the 185 studies in Emergence Delirium with a site in China are open now. Recruiting first, the newest first:

59 more — sign in →

All 64 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 141 Emergence Delirium studies recruiting now, 78 (55%) set no upper age limit and 43 (30%) stop at 75 or younger; 33 take children under 18; 24 take healthy volunteers.

This study: 60 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 185 studies in Emergence Delirium with a site in China, or all of them as a file.
02

Study summary

Exploring the effects of repeated transcranial magnetic stimulation (rTMS) during the perioperative period on the incidence of postoperative delirium, postoperative cognitive dysfunction, and chronic postoperative pain in elderly patients, as well as its possible mechanisms.

Read the detailed description

Patients are recruited one week prior to the trial commencement, during which they are informed about the experimental protocol and associated risks. After obtaining informed consent and signatures, they are enrolled as study participants.Patients who meet the trial criteria are randomly assigned in a 1:1 ratio to the control group (sham rTMS group) and the intervention group (rTMS group, with rTMS intervention applied in the PACU after surgery) in a double-blind manner (with rTMS intervention and postoperative follow-up conducted by different researchers).

Note: This trial includes three co-primary outcomes-postoperative delirium (POD), postoperative cognitive dysfunction (POCD), and chronic postoperative pain (CPSP). To account for the different nature and timelines of these outcomes, the study was designed to include two parallel patient cohorts under a unified protocol:

  1. Elderly patients undergoing gastrointestinal surgery are enrolled primarily for the evaluation of POD, a short-term outcome assessed within 3 days postoperatively.
  2. Elderly patients undergoing thoracic surgery are enrolled to evaluate POCD (at 1 month) and CPSP (at 3 months), which are longer-term outcomes.

These two patient cohorts are studied concurrently but analyzed separately according to outcome-specific follow-up timelines and sample size estimations. A total of 122 gastrointestinal surgery patients were enrolled and analyzed for POD. The maximum estimated sample size is for the POCD and CPSP cohort (n=230). Results will be reported in phases corresponding to the completion of each outcome assessment.

03

Conditions studied

  • Postoperative Delirium
  • Postoperative Cognitive Dysfunction
  • Chronic Post-surgical Pain
04

Who can participate

Ages eligible
60 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥ 60 years;
  • ASA ≤ 3;
  • Elective surgery patients.

Exclusion criteria

Exclusion Criteria:

  • Refusal to sign the consent form;
  • (MMSE) score \< 15;
  • Preoperative neuropsychiatric diseases and history of neurological or psychiatric disorders;
  • Preoperative cranial or scalp injuries;
  • History of drug or alcohol abuse; Visual or auditory impairments, communication difficulties; Presence of metallic implants in the body; Preoperative history of severe cardiovascular disease or severe liver or kidney dysfunction.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
352 participants (actual)

Study arms

  • No intervention
    Sham repetitive transcranial magnetic stimulation (rTMS group)

    After the surgical anesthesia, the patient is transferred to the Post-Anesthesia Care Unit (PACU). The Sham rTMS intervention occurs after the tracheal tube is removed in the PACU.In the sham rTMS group, the setup, including the stimulation site and parameters, is identical to that of the rTMS group. However, although the rTMS device is connected to the patient, no actual stimulation is delivered.

  • Experimental
    repetitive transcranial magnetic stimulation (rTMS group)

    After the surgical anesthesia, the patient is transferred to the Post-Anesthesia Care Unit (PACU). The rTMS intervention occurs after the tracheal tube is removed in the PACU. The stimulation site is the DLPFC (left dorsolateral prefrontal cortex); the stimulation intensity is 100% of the Resting Motor Threshold (RMT); the frequency is 10 Hz; and the total number of pulses is 2000. The pulse characteristics include a duration of 5 seconds per session with a 25-second interval between sessions.

    Device: Repetitive Transcranial Magnetic Stimulation

Interventions

  • DeviceRepetitive Transcranial Magnetic Stimulation

    rTMS intervention timing: rTMS is applied after the tracheal tube is removed in the PACU. Stimulation site: DLPFC (left dorsolateral prefrontal cortex); Stimulation intensity: 100% RMT; Stimulation frequency: 10Hz; Total number of stimulation pulses: 2000. Pulse characteristics: Each duration lasts 5 seconds, with a 25-second interval.

06

What researchers measure

Primary outcomes

  1. Incidence of delirium during the first 3 days after surgery

    Delirium is assessed twice daily (8-10 AM and 6-8 PM) with the Confusion Assessment Method for patients without endotracheal intubation during the first 3 days after surgery.

    Time frame: The first 3 days after surgery

  2. Incidence of Postoperative Cognitive Dysfunction

    Cognitive function assessed with MoCA (Montreal Cognitive Assessment) test on the 30th day after surgery

    Time frame: 1 month after surgery

  3. Incidence of chronic postsurgical pain (CPSP) at 3 months after surgery

    CPSP is defined as pain persisting for at least three months after surgery that was not present before surgery or that had different characteristics, and other possible causes of pain were excluded (e.g., cancer recurrence, infection). Pain intensity is assessed with the numeric rating scale, an 11-point scale where 0=no pain and 10=the worst pain, both at rest and with movement.

    Time frame: At 3 months after surgery

07

Study locations

1 site
  • Affiliated hospital of Nantong University
    Nantong, Jiangsu 226001, China
08

References and documents

Publications

  • Zhou WW, Yang Z, Zhou C, Qiao Q, Zhang YH, Hu J, Gao YN, Chen LE, Yang WW, Qin YB, Zhong CC. Early repetitive transcranial magnetic stimulation for preventing chronic postoperative pain in older adults: a randomized clinical sub-study. BMC Med. 2026 Apr 6;24(1):316. doi: 10.1186/s12916-026-04845-5. PubMed 41943114 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2024 to primary completion in May 2025, 12 months.

Of 186 non-industry interventional studies with no phase under Emergence Delirium, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's 12 months is below that.

Counting every sponsor, half of 186 studies reached it within 19 months; a quarter within 7 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 25, 2024
First posted
May 1, 2024
StartActual
May 3, 2024
Primary completionActual
May 13, 2025
CompletionActual
May 13, 2025
Last update
Sep 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Completed
changed Sep 29, 2026
Primary completion
May 31, 2025→May 13, 2025 (actual)
Sep 29, 2026
Study completion
May 31, 2025→May 13, 2025 (actual)
Sep 29, 2026
Enrollment
230 (estimated)→352 (actual)
Sep 29, 2026
Publications
1 publication citing this study linked from PubMed, e.g. PubMed 41943114 ↗
Sep 29, 2026
Show all 1 update
  1. Sep 29, 2026
    Active, not recruiting→Completed
    Publications 1 publication citing this study linked from PubMed, e.g. PubMed 41943114 ↗
    Primary completion May 31, 2025→May 13, 2025 (now actual)
    Study completion May 31, 2025→May 13, 2025 (now actual)
    Enrollment 230 (estimated)→352 (actual)
    + 3 other changes: verification date, description and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06392919
Lead sponsor
Affiliated Hospital of Nantong University
Responsible party
Chaochao Zhong (Principal Investigator, Affiliated Hospital of Nantong University) — Principal investigator
First posted
May 1, 2024
Start date
May 3, 2024
Primary completion
May 13, 2025
Completion
May 13, 2025
Last update
Sep 29, 2026

Study contacts

Chao-Chao Zhong
principal investigator · Affiliated Hospital of Nantong University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion